Home -
Products -
Others -
Other Targets -
Quercetin 3-O-6-O-(E)-coumaroyl-β-D-glucopyranosyl-(1-2)-α-L-rhamnosyl-7-O-β-D-glucopyranoside
Quercetin 3-O-6-O-(E)-coumaroyl-β-D-glucopyranosyl-(1-2)-α-L-rhamnosyl-7-O-β-D-glucopyranoside
CAS No. 143016-73-3
Quercetin 3-O-6-O-(E)-coumaroyl-β-D-glucopyranosyl-(1-2)-α-L-rhamnosyl-7-O-β-D-glucopyranoside( ——— )
Catalog No. M38446 CAS No. 143016-73-3
Antioxidant agent-18 (compound 5) is a flavonol glycoside with antioxidant activity isolated from Ginkgo biloba. Antioxidant agent-18 scavenges DPPH radicals (IC50: 15.8 μM) and reduces cytochrome c (IC50: 14.7 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameQuercetin 3-O-6-O-(E)-coumaroyl-β-D-glucopyranosyl-(1-2)-α-L-rhamnosyl-7-O-β-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionAntioxidant agent-18 (compound 5) is a flavonol glycoside with antioxidant activity isolated from Ginkgo biloba. Antioxidant agent-18 scavenges DPPH radicals (IC50: 15.8 μM) and reduces cytochrome c (IC50: 14.7 μM).
-
DescriptionAntioxidant agent-18 (compound 5) is a flavonol glycoside with antioxidant activity isolated from Ginkgo biloba. Antioxidant agent-18 scavenges DPPH radicals (IC50: 15.8 μM) and reduces cytochrome c (IC50: 14.7 μM).
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number143016-73-3
-
Formula Weight918.8
-
Molecular FormulaC42H46O23
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Terpin Monohydrate
Terpin hydrate is an expectorant, commonly used to loosen mucus in patients presenting with acute or chronic bronchitis, and related conditions.
-
Combretastatin A-1
Combretastatin A-1 is a potent microtubule inhibitor with anti-tumour and anti-vascular activity, acting through microtubule protein depolymerisation-mediated inactivation of AKT to inhibit the Wnt/β-catenin pathway, and can be used to study hepatocellular carcinoma.
-
SARS-CoV-2 Mpro-IN-9
SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.
Cart
sales@molnova.com